Nonetheless, given the relative harmlessness of vitamin A, a deeper analysis of the impact of the molecule on GCN2 and HIV would rationalize its use in parallel to targeted therapies, including cancer and viral infections. This evidence concerns the gene EIF2AK4 and viral infectious disease.